![Bryan Reasons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Reasons
Präsident bei
CADENCE PHARMACEUTICALS, INC.
Profil
Bryan Marlen Reasons is currently Chairman at Impax Laboratories (Taiwan), Inc., President & Director at Mallinckrodt Hospital Products, Inc., Director at MKG Medical UK Ltd. since 2020, and Chief Financial Officer & Executive Vice President at Mallinckrodt Pharmaceuticals Ltd. Former roles include Independent Director at Societal CDMO, Inc. from 2017 to 2024, Independent Director at Aclaris Therapeutics, Inc. from 2018 to 2024, Vice President-Finance at Cephalon, Inc. from 2010 to 2011, Vice President-Finance at Teva Pharmaceutical Industries Ltd. from 2011 to 2012, Chief Financial Officer & Senior VP-Finance at Impax Laboratories LLC from 2012 to 2018, Senior Manager at PricewaterhouseCoopers LLP in 2003, Vice President-Finance at DuPont de Nemours, Inc. from 2003 to 2005, Chief Financial Officer & Senior Vice President at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. from 2018 to 2019, and Chief Financial Officer & Executive Vice President at Mallinckrodt Plc from 2019 to 2025.
Education includes undergraduate studies at The Pennsylvania State University and an MBA from Widener University conferred in 1992.
Aktive Positionen von Bryan Reasons
| Unternehmen | Position | Beginn |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Präsident | - |
Impax Laboratories (Taiwan), Inc.
 Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Manufactures controlled-release and niche generics | Vorsitzender | - |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Bryan Reasons
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Finanzdirektor/CFO | 22.09.2025 |
MKG Medical UK Ltd.
 MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 15.01.2025 |
| ACLARIS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.06.2024 |
| SOCIETAL CDMO, INC. | Direktor/Vorstandsmitglied | 08.04.2024 |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 01.01.2019 |
Ausbildung von Bryan Reasons
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Engages in development, manufacture and commercialization of generic and branded prescription pharmaceutical products | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Widener University
 Widener University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Societal CDMO, Inc.
 Societal CDMO, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
MKG Medical UK Ltd.
MKG Medical UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
DuPont de Nemours, Inc.
 DuPont de Nemours, Inc. Chemicals: Major DiversifiedProcess Industries Operates as a holding company which develops specialty materials, chemicals, and agricultural products | Process Industries |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Impax Laboratories (Taiwan), Inc.
Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Manufactures controlled-release and niche generics | Health Technology |
Amneal Pharmaceuticals, Inc.
 Amneal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes essential medicines | Health Technology |
